Paths to Recovery
Cincinnati children’s HLH research points to treatment for COVID-19 cytokine storms
PureTech to develop drug to treat lung scarring in COVID-19 patients
Artificial intelligence spots COVID-19 in chest X-rays
PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical Trial
COVID-19 Mouse CRISPR Engineered to Recapitulate Human COVID-19
Pediatric scoring scale helps surgeons decide whether to operate during COVID-19 delays
Coronavirus – Weekly update – 27 May 2020
5 Signs a Company Is Poised to Pivot
WVU, through partnerships, producing thousands of swabs for COVID-19 testing
Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
Short-term recovery due for platinum and palladium
South Korea’s fintech sandbox raises $110 million funding
Equities Achieve Low Earth Orbit Ahead of Space-X
Battling disease with ultraviolet light
Is the housing market already rebounding from COVID-19?
Beware of false negatives in diagnostic testing of COVID-19
Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
Merck Joins Race For Covid-19 Vaccine; Shares Rise 4.4% In Pre-Market Trading
Regeneron to buy back $5 billion stake held by Sanofi
WHO halts hydroxychloroquine trial in COVID-19 following safety concerns
Macro Briefing | 26 May 2020
Oxford Uni coronavirus vaccine ‘has 50% chance of success’
Novavax Begins Human Testing For Covid-19 Vaccine, Expects Results In July
7 "Perfect 10" Stocks to Buy Now
Public disclosure of COVID-19 cases is more effective than lockdowns
AngloGold Halts Production At World’s Deepest Gold Mine, Due To Covid-19 Outbreak
Coronavirus dashboard: emphasis on testing